OCAS

Astellas Pharma Inc.

Application Filed: 2000-10-16
Trademark Application Details
Trademark Logo OCAS

Mark For: OCAS® trademark registration is intended to cover the categories of controlled release delivery formulation sold as an integral component of oral pharmaceutical preparations providing continuing drug release and absorption for a prolonged period of time for the treatment of disease or health-related conditions involving blood and blood-forming organs, the cardiac circulatory systems, the peripheral vascular circulatory system, the endocrine system, the genitourinary system, the immune system, infectious and parasitic conditions, the upper and lower digestive system, mental disorders, metabolic disorders, multi-system and ill defined conditions, musculoskeletal systems and connective tissue, neoplasms, the nervous system, nutritional disorders, pregnancy, the respiratory system, sensory organ conditions, skin and subcutaneous conditions. [all]

Status

2022-09-25 UTC
DEAD REGISTRATION Cancelled Invalidated
The trademark application was registered, but subsequently it was cancelled or invalidated and removed from the registry.


Research OneLook Acronym Finder
Serial Number76148225
Registration Number3403943
Mark Literal ElementsOCAS
Mark Drawing Type1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark TypeTRADEMARK. SERVICE MARK
Standard Character ClaimNo
RegisterPRINCIPAL
Current LocationPUBLICATION AND ISSUE SECTION 2008-04-01
Basis44(e)
Class StatusSECTION 8 - CANCEL
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseNo
Filed ITUYes
44D FiledNo
44E CurrentYes
66A CurrentNo
Current BasisNo
No BasisNo
Cancellation Code2
Domestic RepresentativeHanson Bridgett Marcus Vlahos & Rudy, LLP
Attorney NameBarbara L. Friedman
Attorney Docket Number26914.1
Law Office AssignedL10
Employee NamePEREZ, STEVEN M

Timeline

2000-10-16Application Filed
2008-01-15Published
2008-01-15Published for Opposition
2008-04-01Location: PUBLICATION AND ISSUE SECTION
2008-04-01Trademark Registered
2014-11-07Cancelled
2014-11-07Status: Dead/Cancelled
2014-11-07Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this
2018-07-08Transaction Date

Trademark Parties (Applicants & Owners)

Party: ASTELLAS PHARMA INC.
Address3-11, NIHONBASHI-HONCHO 2-CHOME CHUO-KU, TOKYO JAPAN
Legal Entity TypeCorporation
Legal Entity StateJAPAN
Party: Yamanouchi Pharma Technologies, Inc.
AddressStanford Research Park 1050 Arastradero Road Palo Alto DE 94304
Legal Entity Type
Legal Entity State JP

*multiple parties listed, check assignment documents for ownership information

Attorney of Record

Barbara L. Friedman
Hanson Bridgett LLP
425 Market Street, 26th Floor
San Francisco CA 94105-5401

Good, Services, and Codes

(CANCELLED)
IC 005. US 006 018 044 046 051 052. G & S: CONTROLLED RELEASE DELIVERY FORMULATION SOLD AS AN INTEGRAL COMPONENT OF ORAL PHARMACEUTICAL PREPARATIONS PROVIDING CONTINUING DRUG RELEASE AND ABSORPTION FOR A PROLONGED PERIOD OF TIME FOR THE TREATMENT OF DISEASE OR HEALTH-RELATED CONDITIONS INVOLVING BLOOD AND BLOOD-FORMING ORGANS, THE CARDIAC CIRCULATORY SYSTEMS, THE PERIPHERAL VASCULAR CIRCULATORY SYSTEM, THE ENDOCRINE SYSTEM, THE GENITOURINARY SYSTEM, THE IMMUNE SYSTEM, INFECTIOUS AND PARASIT
IC CONDITIONS, THE UPPER AND LOWER DIGESTIVE SYSTEM, MENTAL DISORDERS, METABOL
IC DISORDERS, MULTI-SYSTEM AND ILL DEFINED CONDITIONS, MUSCULOSKELETAL SYSTEMS AND CONNECTIVE TISSUE, NEOPLASMS, THE NERVOUS SYSTEM, NUTRITIONAL DISORDERS, PREGNANCY, THE RESPIRATORY SYSTEM, SENSORY ORGAN CONDITIONS, SKIN AND SUBCUTANEOUS CONDITIONS(CANCELLED)
IC 040. US 100 103 106. G & S: MANUFACTURE OF ORAL CONTROLLED- RELEASE PHARMACEUTICAL PRODUCTS TO THE ORDER OR SPECIFICATION OF OTHERS

International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:40
U.S. Codes:100,103,106
Type CodeType
GS0051CONTROLLED RELEASE DELIVERY FORMULATION SOLD AS AN INTEGRAL COMPONENT OF ORAL PHARMACEUTICAL PREPARATIONS PROVIDING CONTINUING DRUG RELEASE AND ABSORPTION FOR A PROLONGED PERIOD OF TIME FOR THE TREATMENT OF DISEASE OR HEALTH-RELATED CONDITIONS INVOLVING BLOOD AND BLOOD-FORMING ORGANS, THE CARDIAC CIRCULATORY SYSTEMS, THE PERIPHERAL VASCULAR CIRCULATORY SYSTEM, THE ENDOCRINE SYSTEM, THE GENITOURINARY SYSTEM, THE IMMUNE SYSTEM, INFECTIOUS AND PARASITIC CONDITIONS, THE UPPER AND LOWER DIGESTIVE SYSTEM, MENTAL DISORDERS, METABOLIC DISORDERS, MULTI-SYSTEM AND ILL DEFINED CONDITIONS, MUSCULOSKELETAL SYSTEMS AND CONNECTIVE TISSUE, NEOPLASMS, THE NERVOUS SYSTEM, NUTRITIONAL DISORDERS, PREGNANCY, THE RESPIRATORY SYSTEM, SENSORY ORGAN CONDITIONS, SKIN AND SUBCUTANEOUS CONDITIONS

Trademark Filing History

DescriptionDateProceeding Number
CANCELLED SEC. 8 (6-YR)2014-11-07
REGISTERED-PRINCIPAL REGISTER2008-04-01
TEAS CHANGE OF CORRESPONDENCE RECEIVED2008-03-11
PUBLISHED FOR OPPOSITION2008-01-15
NOTICE OF PUBLICATION2007-12-26
LAW OFFICE PUBLICATION REVIEW COMPLETED2007-12-1278288
APPROVED FOR PUB - PRINCIPAL REGISTER2007-12-11
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY2007-10-24
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY2007-08-06
TEAS/EMAIL CORRESPONDENCE ENTERED2007-08-0278288
CORRESPONDENCE RECEIVED IN LAW OFFICE2007-08-0278288
ASSIGNED TO LIE2007-08-0178288
TEAS RESPONSE TO OFFICE ACTION RECEIVED2007-07-17
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2007-05-04
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2007-05-04
PREVIOUS ALLOWANCE COUNT WITHDRAWN2007-02-08
NON-FINAL ACTION WRITTEN2007-02-0874301
NON-FINAL ACTION E-MAILED2007-02-086325
ASSIGNED TO EXAMINER2007-02-0874290
ATTORNEY REVIEW COMPLETED2007-02-0774301
ASSIGNED TO EXAMINER2007-01-2374301
TEAS CHANGE OF CORRESPONDENCE RECEIVED2006-12-27
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED2006-11-21
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP2006-10-04
1(B) BASIS DELETED; NEW BASIS REQUESTED2006-09-1567832
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED2006-08-3067832
PETITION TO DIRECTOR - CHANGE BASIS - RECEIVED2006-08-0767832
PAPER RECEIVED2006-08-07
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP2006-04-05
TEAS CHANGE OF CORRESPONDENCE RECEIVED2006-03-30
ASSIGNED TO EXAMINER2006-02-1774301
NOTICE OF ALLOWANCE CANCELLED2006-01-3167832
TEAS EXTENSION RECEIVED2006-01-30
SOU EXTENSION 5 GRANTED2006-01-3098765
SOU EXTENSION 5 FILED2006-01-3098765
SOU EXTENSION 4 GRANTED2005-08-1261813
TEAS EXTENSION RECEIVED2005-08-05
SOU EXTENSION 4 FILED2005-08-0561813
SOU EXTENSION 3 GRANTED2005-02-2371427
TEAS EXTENSION RECEIVED2005-02-02
SOU EXTENSION 3 FILED2005-02-0271427
TEAS CHANGE OF CORRESPONDENCE RECEIVED2004-10-20
SOU EXTENSION 2 GRANTED2004-08-31
CASE FILE IN TICRS2004-08-18
PAPER RECEIVED2004-08-02
SOU EXTENSION 2 FILED2004-07-30
SOU EXTENSION 1 GRANTED2004-02-22
SOU EXTENSION 1 FILED2004-02-05
PAPER RECEIVED2004-02-05
NOA MAILED - SOU REQUIRED FROM APPLICANT2003-08-05
PUBLISHED FOR OPPOSITION2003-05-13
NOTICE OF PUBLICATION2003-04-23
APPROVED FOR PUB - PRINCIPAL REGISTER2002-02-11
CORRESPONDENCE RECEIVED IN LAW OFFICE2001-08-20
NON-FINAL ACTION MAILED2001-03-13
ASSIGNED TO EXAMINER2001-03-0374290
ASSIGNED TO EXAMINER2001-02-2167443

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed